Login to Your Account



Clinic roundup


Monday, December 16, 2013
Neumedicines Inc., of Pasadena, Calif., reported data from a study in healthy human subjects showing that Hemamax (recombinant human interleukin-12, or IL-12) works by promoting NK cell migration and also increases CSCL10, co-receptors IL-12Rbeta2 and CXCR3 and bright CD56.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription